Welcure Drugs & Pharmaceuticals Ltd — Board Meeting, 13-11-2025: Board Meeting
13-11-2025 | 05:35 pm
13-11-2025 | 05:35 pm
WELCURE's Q2 & H1 FY26 financial results for Sep 30, 2025: Auditors issued a disclaimer of opinion due to insufficient documents for sales, purchases, inventory, loans, receivables, and assets. Management cannot estimate the impact.
No comments yet. Be the first to comment!
